Generation Lab, founded by former UC Berkeley scientist Irina Conboy, claims a secret two-drug combination can mimic the rejuvenating effects of plasma exchange.

Generation Lab is promoting an injectable treatment, dubbed 1 Generation, which it claims blocks the systemic spread of aging and restores health to tissues. The company, led by CEO Alina Su and scientific founder Irina Conboy, asserts the treatment mimics the benefits of plasma exchange without requiring bodily fluid removal. While the company is building buzz among high-profile figures, it has not disclosed the specific drugs involved, citing a desire to prevent imitators.

Scientific Background and Methodology

Irina Conboy, a former researcher at UC Berkeley, previously gained recognition for studies showing that young blood can rejuvenate old animals and that old blood can negatively impact young ones. In 2020, she explored replacing old plasma with a mixture of albumin and salt water to reset the body's molecular signals. Her current work at Generation Lab utilizes a microfluidic testing system to identify drug combinations that allow human cells to remain young even when exposed to old blood serum.

Clinical Trials and Medical Oversight

Generation Lab plans to launch a clinical trial involving at least 100 people, which the company states will be free to participants. The trial is set to be led by doctors practicing alternative medicine, including Matt Cook of BioReset Medical. While some early users, including Cook, reported positive effects like increased mental clarity and reduced aches, other medical professionals have expressed skepticism regarding the lack of transparency about the drug ingredients.